El-Hibri Fuad
Insider CIK 1380185 · EBS Executive Chairman, Director, 10% owner · APVO Board of Directors, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | J Other | 2021-12-03 | 2021-12-07 | 107,807 | — | $0 | 107,807 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | J Other | 2021-12-03 | 2021-12-07 | 7,373 | — | $0 | 7,373 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | J Other | 2021-12-03 | 2021-12-07 | 9,819 | — | $0 | 9,819 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2021-12-03 | 2021-12-07 | 3,018,644 | — | $0 | 3,018,644 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2021-12-03 | 2021-12-07 | 206,434 | — | $0 | 206,434 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2021-12-03 | 2021-12-07 | 274,930 | — | $0 | 274,930 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 893 | — | $0 | 893 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 2,678 | — | $0 | 2,678 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2021-02-24 | 2021-02-26 | 13,906 | — | $0 | 13,906 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2021-02-24 | 2021-02-26 | 27,808 | — | $0 | 27,808 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-11-10 | 2020-11-12 | 19,391 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-11-10 | 2020-11-12 | 19,391 | $26.45 | $512.9K | 1,143,379 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-11-10 | 2020-11-12 | 19,391 | $88.21 | $1.71M | 1,123,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-11-09 | 2020-11-12 | 20,000 | — | $0 | 19,391 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-11-09 | 2020-11-12 | 20,000 | $95.26 | $1.91M | 1,123,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-11-09 | 2020-11-12 | 20,000 | $26.45 | $529.0K | 1,143,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-11-03 | 2020-11-04 | 20,000 | — | $0 | 39,391 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-11-03 | 2020-11-04 | 20,000 | $90.74 | $1.81M | 1,123,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-11-03 | 2020-11-04 | 20,000 | $26.45 | $529.0K | 1,143,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-11-02 | 2020-11-04 | 20,000 | — | $0 | 59,391 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-11-02 | 2020-11-04 | 20,000 | $90.44 | $1.81M | 1,123,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-11-02 | 2020-11-04 | 20,000 | $26.45 | $529.0K | 1,143,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-09-24 | 2020-09-25 | 12,535 | $98.85 | $1.24M | 1,123,988 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-09-23 | 2020-09-25 | 13,000 | $100.58 | $1.31M | 1,136,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-09-17 | 2020-09-18 | 20,000 | $100.68 | $2.01M | 1,149,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-09-16 | 2020-09-18 | 20,000 | $102.48 | $2.05M | 1,169,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-09-10 | 2020-09-11 | 20,000 | $102.66 | $2.05M | 1,189,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-09-09 | 2020-09-11 | 20,000 | $102.80 | $2.06M | 1,209,523 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,339 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 892 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,785 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 1,322 | — | $0 | 1,322 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 170 | — | $0 | 170 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-02 | 2021-02-17 | 3,571 | — | $0 | 3,571 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-30 | 2020-05-01 | 20,000 | $74.01 | $1.48M | 1,229,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-29 | 2020-05-01 | 20,000 | $74.24 | $1.48M | 1,249,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-23 | 2020-04-24 | 20,000 | $68.49 | $1.37M | 1,269,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-22 | 2020-04-24 | 20,000 | $66.81 | $1.34M | 1,289,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-16 | 2020-04-20 | 20,000 | $62.47 | $1.25M | 1,309,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-15 | 2020-04-15 | 12,537 | $62.58 | $784.6K | 1,329,523 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-14 | 2020-04-15 | 6,261 | $62.99 | $394.4K | 1,342,060 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-13 | 2020-04-15 | 17,071 | $62.25 | $1.06M | 1,348,321 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-09 | 2020-04-10 | 23,716 | $61.83 | $1.47M | 1,365,392 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-08 | 2020-04-10 | 13,000 | $60.75 | $789.8K | 1,413,470 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-08 | 2020-04-10 | 24,362 | $61.34 | $1.49M | 1,389,108 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-07 | 2020-04-08 | 14,336 | $60.76 | $871.1K | 1,426,470 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-04-06 | 2020-04-08 | 28,240 | $60.50 | $1.71M | 1,440,806 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-27 | 2020-02-28 | 9,794 | — | $0 | 37,980 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-02-27 | 2020-02-28 | 3,854 | $58.42 | $225.2K | 1,478,883 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-27 | 2020-02-28 | 9,794 | — | $0 | 1,482,737 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-27 | 2020-02-28 | 9,837 | $56.97 | $560.4K | 1,469,046 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-26 | 2020-02-28 | 6,429 | — | $0 | 47,774 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-26 | 2020-02-28 | 13,619 | $58.70 | $799.4K | 1,472,943 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-02-26 | 2020-02-28 | 2,365 | $59.91 | $141.7K | 1,482,663 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-26 | 2020-02-28 | 6,429 | — | $0 | 1,489,092 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2020-02-26 | 2020-02-28 | 2,530 | $59.91 | $151.6K | 1,486,562 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 39,061 | — | $0 | 39,061 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 19,532 | — | $0 | 60,213 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-25 | 2020-02-27 | 6,010 | — | $0 | 54,203 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-25 | 2020-02-27 | 6,010 | — | $0 | 1,485,028 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-21 | 2020-02-24 | 18,567 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-21 | 2020-02-24 | 18,567 | $25.62 | $475.7K | 1,497,585 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-21 | 2020-02-24 | 18,567 | $64.90 | $1.20M | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-20 | 2020-02-24 | 4,751 | — | $0 | 18,567 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-20 | 2020-02-24 | 4,751 | $25.62 | $121.7K | 1,483,769 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-20 | 2020-02-24 | 4,751 | $64.90 | $308.3K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-18 | 2020-02-19 | 15,614 | — | $0 | 23,318 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-18 | 2020-02-19 | 15,614 | $25.62 | $400.0K | 1,494,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-18 | 2020-02-19 | 15,614 | $63.90 | $997.7K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-14 | 2020-02-19 | 4,386 | — | $0 | 38,932 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-14 | 2020-02-19 | 4,386 | $63.90 | $280.3K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-14 | 2020-02-19 | 4,386 | $25.62 | $112.4K | 1,483,404 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-12 | 2020-02-13 | 13,720 | — | $0 | 43,318 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-12 | 2020-02-13 | 13,720 | $25.62 | $351.5K | 1,492,738 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-12 | 2020-02-13 | 13,720 | $62.90 | $863.0K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-11 | 2020-02-13 | 6,280 | — | $0 | 57,038 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-11 | 2020-02-13 | 6,280 | $62.90 | $395.0K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-11 | 2020-02-13 | 6,280 | $25.62 | $160.9K | 1,485,298 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-06 | 2020-02-13 | 11,684 | — | $0 | 63,318 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-06 | 2020-02-07 | 11,684 | $61.90 | $723.2K | 1,419,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-06 | 2020-02-13 | 11,684 | $25.62 | $299.3K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-05 | 2020-02-13 | 8,316 | — | $0 | 75,002 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-05 | 2020-02-13 | 20,000 | — | $0 | 83,318 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-02-05 | 2020-02-13 | 20,000 | — | $0 | 103,318 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-02-05 | 2020-02-07 | 48,316 | $60.66 | $2.93M | 1,430,702 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-05 | 2020-02-13 | 8,316 | $25.62 | $213.1K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-05 | 2020-02-13 | 20,000 | $25.62 | $512.4K | 1,519,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-02-05 | 2020-02-13 | 20,000 | $25.62 | $512.4K | 1,499,018 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-08-12 | 2019-08-13 | 100,000 | $0.76 | $76.0K | 1,124,536 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-29 | 2019-07-30 | 55,015 | $0.83 | $45.7K | 1,024,536 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-23 | 2019-07-24 | 10,000 | $0.90 | $9.0K | 969,521 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-22 | 2019-07-23 | 30,000 | $0.89 | $26.7K | 959,521 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-19 | 2019-07-19 | 26,460 | $0.90 | $23.8K | 929,521 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-18 | 2019-07-18 | 14,404 | $0.87 | $12.5K | 903,061 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-17 | 2019-07-18 | 19,136 | $0.87 | $16.6K | 888,657 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-16 | 2019-07-16 | 11,375 | $0.85 | $9.7K | 869,521 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-11 | 2019-07-12 | 14,691 | $0.85 | $12.5K | 858,146 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-07-10 | 2019-07-11 | 18,919 | $0.85 | $16.1K | 843,455 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-06-01 | 2019-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2019-02-28 | 2019-02-28 | 9,722 | — | $0 | 40,681 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2019-02-28 | 2019-02-28 | 6,987 | $58.47 | $408.5K | 1,473,122 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2019-02-28 | 2019-02-28 | 9,722 | — | $0 | 1,482,844 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-02-28 | 2019-02-28 | 3,826 | $58.71 | $224.6K | 1,479,018 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2019-02-27 | 2019-02-28 | 9,794 | — | $0 | 50,403 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2019-02-27 | 2019-02-28 | 10,369 | $58.24 | $603.9K | 1,472,801 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2019-02-27 | 2019-02-28 | 9,794 | — | $0 | 1,482,595 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-02-27 | 2019-02-28 | 2,486 | $57.98 | $144.1K | 1,480,109 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2019-02-26 | 2019-02-28 | 6,430 | — | $0 | 42,168 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2019-02-26 | 2019-02-28 | 36,053 | — | $0 | 36,053 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2019-02-26 | 2019-02-28 | 18,029 | — | $0 | 60,197 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2019-02-26 | 2019-02-28 | 6,430 | — | $0 | 1,484,736 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-02-26 | 2019-02-28 | 1,566 | $61.01 | $95.5K | 1,483,170 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2019-02-26 | 2019-02-28 | 10,369 | $59.65 | $618.5K | 1,478,306 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-11-27 | 2019-02-20 | 20,832 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-11-27 | 2019-02-20 | 20,832 | $13.38 | $278.7K | 1,509,507 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-11-27 | 2019-02-20 | 20,832 | $69.59 | $1.45M | 1,488,675 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-11-27 | 2018-11-28 | 20,832 | $69.59 | $1.45M | 1,407,670 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-11-26 | 2019-02-20 | 25,000 | — | $0 | 20,832 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-11-26 | 2019-02-20 | 25,000 | $13.38 | $334.5K | 1,513,675 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-11-26 | 2018-11-28 | 25,000 | $69.96 | $1.75M | 1,428,502 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-11-20 | 2019-02-20 | 15,173 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-11-20 | 2019-02-20 | 15,173 | $14.44 | $219.1K | 1,503,848 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-11-20 | 2018-11-21 | 15,173 | $70.03 | $1.06M | 1,453,502 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-11-19 | 2019-02-20 | 20,000 | — | $0 | 15,173 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-11-19 | 2019-02-20 | 20,000 | $14.44 | $288.8K | 1,508,675 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-11-19 | 2018-11-21 | 20,000 | $69.54 | $1.39M | 1,468,675 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-08-14 | 2018-08-15 | 16,318 | $56.57 | $923.1K | 1,488,675 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-08-13 | 2018-08-15 | 20,000 | $55.50 | $1.11M | 1,504,993 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-07-12 | 2018-07-16 | 2,600 | $54.52 | $141.8K | 1,524,993 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-07-12 | 2018-07-16 | 12,400 | $54.50 | $675.8K | 1,527,593 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-07-09 | 2018-07-11 | 15,000 | $53.61 | $804.1K | 1,539,993 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-06-01 | 2018-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-03-09 | 2018-03-13 | 13,237 | — | $0 | 48,598 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2018-03-09 | 2018-03-13 | 3,224 | $51.84 | $167.1K | 1,554,993 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-03-09 | 2018-03-13 | 13,237 | — | $0 | 1,558,217 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-02-28 | 2018-03-01 | 9,723 | — | $0 | 61,835 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2018-02-28 | 2018-03-01 | 2,368 | $49.97 | $118.3K | 1,544,980 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-02-28 | 2018-03-01 | 9,723 | — | $0 | 1,547,348 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-02-27 | 2018-03-01 | 9,794 | — | $0 | 71,558 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2018-02-27 | 2018-03-01 | 38,577 | — | $0 | 38,577 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2018-02-27 | 2018-03-01 | 19,288 | — | $0 | 81,352 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-02-27 | 2018-03-01 | 9,794 | — | $0 | 1,540,010 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2018-02-27 | 2018-03-01 | 2,385 | $49.64 | $118.4K | 1,537,625 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-11-29 | 2017-11-30 | 27,983 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-29 | 2017-11-30 | 27,983 | $42.08 | $1.18M | 1,530,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-11-29 | 2017-11-30 | 27,983 | $22.03 | $616.5K | 1,558,199 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-11-28 | 2017-11-30 | 20,000 | — | $0 | 27,983 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-28 | 2017-11-30 | 20,000 | $41.59 | $831.8K | 1,530,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-11-28 | 2017-11-30 | 20,000 | $22.03 | $440.6K | 1,550,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-11-14 | 2017-11-17 | 20,000 | — | $0 | 47,983 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-14 | 2017-11-15 | 20,000 | $40.05 | $801.0K | 1,490,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-14 | 2017-11-17 | 20,000 | $40.05 | $801.0K | 1,530,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-11-14 | 2017-11-17 | 20,000 | $22.03 | $440.6K | 1,550,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-11-13 | 2017-11-17 | 20,000 | — | $0 | 67,983 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-13 | 2017-11-15 | 20,000 | $40.69 | $813.8K | 1,510,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-13 | 2017-11-17 | 20,000 | $40.69 | $813.8K | 1,530,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-11-13 | 2017-11-17 | 20,000 | $22.03 | $440.6K | 1,550,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-09-29 | 2017-09-29 | 25,000 | $40.50 | $1.01M | 1,530,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-09-27 | 2017-09-29 | 25,000 | $39.50 | $987.5K | 1,555,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-09-14 | 2017-09-14 | 23,547 | $38.50 | $906.6K | 1,580,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-09-12 | 2017-09-14 | 1,453 | $38.50 | $55.9K | 1,603,763 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-09-07 | 2017-09-08 | 16,439 | $37.50 | $616.5K | 1,605,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-09-05 | 2017-09-06 | 3,100 | $37.50 | $116.3K | 1,621,655 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-08-31 | 2017-09-01 | 5,461 | $37.50 | $204.8K | 1,624,755 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-07-27 | 2017-07-28 | 25,000 | $36.50 | $912.5K | 1,630,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-07-20 | 2017-07-21 | 25,000 | $35.50 | $887.5K | 1,655,216 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-03-10 | 2017-03-10 | 20,554 | — | $0 | 62,064 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-03-10 | 2017-03-10 | 6,089 | $31.05 | $189.1K | 1,680,216 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-03-10 | 2017-03-10 | 20,554 | — | $0 | 1,686,305 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-03-09 | 2017-03-10 | 13,236 | — | $0 | 82,618 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-03-09 | 2017-03-10 | 3,621 | $30.98 | $112.2K | 1,665,751 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-03-09 | 2017-03-10 | 13,236 | — | $0 | 1,669,372 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2017-02-28 | 2017-03-02 | 29,382 | — | $0 | 105,576 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 9,722 | — | $0 | 95,854 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2017-02-28 | 2017-03-02 | 58,747 | — | $0 | 58,747 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 2,659 | $30.63 | $81.4K | 1,656,136 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-02-28 | 2017-03-02 | 9,722 | — | $0 | 1,658,795 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 18,750 | — | $0 | 18,750 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-27 | 2016-05-27 | 9,835 | $43.50 | $427.8K | 1,649,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-26 | 2016-05-26 | 24,594 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-26 | 2016-05-26 | 24,594 | $15.91 | $391.3K | 1,698,667 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-26 | 2016-05-26 | 15,165 | $43.50 | $659.7K | 1,658,908 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-26 | 2016-05-26 | 24,594 | $42.90 | $1.06M | 1,674,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-25 | 2016-05-25 | 20,000 | — | $0 | 24,594 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-25 | 2016-05-25 | 20,000 | $42.57 | $851.4K | 1,674,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-25 | 2016-05-25 | 20,000 | $15.91 | $318.2K | 1,694,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-24 | 2016-05-25 | 20,000 | — | $0 | 44,594 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-24 | 2016-05-25 | 20,000 | $42.26 | $845.2K | 1,674,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-24 | 2016-05-25 | 20,000 | $15.91 | $318.2K | 1,694,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-23 | 2016-05-25 | 20,000 | — | $0 | 64,594 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-23 | 2016-05-25 | 20,000 | $15.91 | $318.2K | 1,719,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-23 | 2016-05-25 | 20,000 | $42.76 | $855.2K | 1,699,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-23 | 2016-05-25 | 25,000 | $42.50 | $1.06M | 1,674,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-12 | 2016-05-13 | 25,000 | $38.71 | $967.8K | 1,699,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-04-22 | 2016-04-25 | 4,209 | $40.50 | $170.5K | 1,724,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-04-18 | 2016-04-20 | 20,791 | $40.50 | $842.0K | 1,728,282 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-04-06 | 2016-04-08 | 25,000 | $38.50 | $962.5K | 1,774,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-04-06 | 2016-04-08 | 25,000 | $39.50 | $987.5K | 1,749,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-11 | 2016-03-15 | 6,967 | — | $0 | 69,196 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-11 | 2016-03-15 | 6,967 | — | $0 | 1,800,975 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2016-03-11 | 2016-03-15 | 1,902 | $34.22 | $65.1K | 1,799,073 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-10 | 2016-03-11 | 18,746 | — | $0 | 76,163 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2016-03-10 | 2016-03-11 | 5,128 | $34.38 | $176.3K | 1,794,008 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-10 | 2016-03-11 | 18,746 | — | $0 | 1,799,136 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-09 | 2016-03-11 | 12,073 | — | $0 | 94,909 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-09 | 2016-03-11 | 12,073 | — | $0 | 1,783,678 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2016-03-09 | 2016-03-11 | 3,288 | $34.60 | $113.8K | 1,780,390 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2016-03-01 | 2016-03-03 | 53,192 | — | $0 | 53,192 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2016-03-01 | 2016-03-11 | 26,303 | — | $0 | 106,982 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2016-03-01 | 2016-03-03 | 26,303 | — | $0 | 1,797,908 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-11-19 | 2015-11-19 | 27,900 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-11-19 | 2015-11-19 | 27,900 | $18.90 | $527.3K | 1,870,155 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-11-19 | 2015-11-19 | 17,871 | $37.50 | $670.2K | 1,852,284 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-11-13 | 2015-11-16 | 20,000 | — | $0 | 27,900 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-11-13 | 2015-11-16 | 13,013 | $36.50 | $475.0K | 1,842,255 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-11-13 | 2015-11-16 | 20,000 | $18.90 | $378.0K | 1,855,268 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-11-09 | 2015-11-10 | 20,000 | — | $0 | 47,900 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-11-09 | 2015-11-10 | 20,000 | $18.90 | $378.0K | 1,848,493 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-11-09 | 2015-11-10 | 13,225 | $35.50 | $469.5K | 1,835,268 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-11-06 | 2015-11-06 | 20,000 | — | $0 | 67,900 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-11-06 | 2015-11-06 | 13,450 | $34.50 | $464.0K | 1,828,493 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-11-06 | 2015-11-06 | 20,000 | $18.90 | $378.0K | 1,841,943 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-11-03 | 2015-11-04 | 20,000 | — | $0 | 87,900 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-11-03 | 2015-11-04 | 20,000 | $18.90 | $378.0K | 1,835,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-11-03 | 2015-11-04 | 13,689 | $33.50 | $458.6K | 1,821,943 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-08-10 | 2015-08-10 | 30,000 | $35.50 | $1.06M | 1,815,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-08-06 | 2015-08-07 | 29,766 | $34.50 | $1.03M | 1,845,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-07-20 | 2015-07-22 | 234 | $34.50 | $8.1K | 1,875,398 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-06-22 | 2015-06-22 | 30,000 | $33.00 | $990.0K | 1,875,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-06-19 | 2015-06-22 | 30,000 | $32.50 | $975.0K | 1,905,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-06-18 | 2015-06-22 | 14,564 | $32.00 | $466.0K | 1,935,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-06-15 | 2015-06-15 | 368 | $32.00 | $11.8K | 1,950,196 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-06-12 | 2015-06-15 | 15,068 | $32.03 | $482.6K | 1,950,564 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-06-11 | 2015-06-15 | 30,000 | $32.26 | $967.8K | 1,965,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2015-03-12 | 2015-03-13 | 1,463 | $28.67 | $41.9K | 1,995,632 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2015-03-11 | 2015-03-13 | 1,906 | $28.99 | $55.3K | 1,997,095 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2015-03-10 | 2015-03-13 | 72,413 | — | $0 | 72,413 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2015-03-10 | 2015-03-13 | 5,128 | $29.00 | $148.7K | 1,999,001 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2015-03-10 | 2015-03-13 | 36,219 | — | $0 | 2,004,129 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-01-20 | 2015-01-21 | 33,333 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-01-20 | 2015-01-21 | 33,333 | $7.00 | $233.3K | 1,983,235 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-01-20 | 2015-01-21 | 7,303 | $28.24 | $206.2K | 1,967,910 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-01-20 | 2015-01-21 | 8,022 | $27.16 | $217.9K | 1,975,213 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-12-11 | 2014-12-11 | 68,413 | $26.00 | $1.78M | 1,949,902 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-12-10 | 2014-12-11 | 416 | $26.00 | $10.8K | 2,018,315 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-12-09 | 2014-12-11 | 50,512 | $26.00 | $1.31M | 2,018,731 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-28 | 2014-12-01 | 5,135 | $25.00 | $128.4K | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-28 | 2014-12-01 | 14,355 | $25.00 | $358.9K | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-28 | 2014-12-01 | 13,597 | $25.00 | $339.9K | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-26 | 2014-12-01 | 1,490 | $25.00 | $37.3K | 14,355 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-25 | 2014-11-26 | 2,126 | $25.00 | $53.1K | 5,135 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-24 | 2014-11-26 | 6,388 | $25.00 | $159.7K | 7,261 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-24 | 2014-11-26 | 500 | $25.00 | $12.5K | 13,597 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-12 | 2014-11-14 | 115 | $25.00 | $2.9K | 14,097 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-12 | 2014-11-14 | 2,196 | $25.00 | $54.9K | 13,649 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-09-02 | 2014-11-10 | 1,633 | $25.00 | $40.8K | 14,212 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-09-02 | 2014-09-03 | 1,633 | $25.00 | $40.8K | 14,212 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-08-26 | 2014-11-10 | 70,796 | $25.00 | $1.77M | 2,069,243 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-08-26 | 2014-08-27 | 70,769 | $25.00 | $1.77M | 2,069,243 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-03-14 | 2014-04-08 | 3,659 | $27.06 | $99.0K | 2,140,039 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-03-12 | 2014-03-14 | 1,463 | $27.15 | $39.7K | 2,144,934 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-03-12 | 2014-03-14 | 3,659 | $27.06 | $99.0K | 2,141,275 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2014-03-11 | 2014-03-12 | 112,479 | — | $0 | 112,479 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-03-11 | 2014-03-12 | 1,887 | $28.09 | $53.0K | 2,144,510 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2014-03-11 | 2014-03-12 | 56,240 | — | $0 | 2,146,397 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2013-05-31 | 2013-06-04 | 347,488 | — | $0 | 2,090,157 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2013-04-18 | 2013-04-19 | 62,851 | $15.05 | $945.9K | 1,742,669 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2013-04-17 | 2013-04-19 | 52,021 | $15.02 | $781.4K | 1,805,520 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-14 | 2013-04-18 | 3,659 | $14.46 | $52.9K | 1,857,532 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2013-03-12 | 2013-04-19 | 20,902 | — | $0 | 1,861,191 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-12 | 2013-04-19 | 1,463 | $14.67 | $21.5K | 1,840,289 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2013-03-12 | 2013-03-12 | 41,804 | — | $0 | 41,804 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-12 | 2013-03-12 | 1,717 | $14.67 | $25.2K | 1,839,445 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2013-03-12 | 2013-03-12 | 20,902 | — | $0 | 1,860,347 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-08 | 2013-04-19 | 3,818 | $15.22 | $58.1K | 1,841,752 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-08 | 2013-03-12 | 4,408 | $15.22 | $67.1K | 1,841,162 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-08 | 2013-03-18 | 4,294 | $14.46 | $62.1K | 1,856,053 | SEC↗ |
| EBS Emergent BioSolutions Inc. | G Gift | 2012-12-14 | 2012-12-14 | 13,333 | — | $0 | 13,333 | SEC↗ |
| EBS Emergent BioSolutions Inc. | G Gift | 2012-12-14 | 2012-12-14 | 176,378 | — | $0 | 127,721 | SEC↗ |
| EBS Emergent BioSolutions Inc. | G Gift | 2012-12-14 | 2012-12-14 | 224,628 | — | $0 | 224,628 | SEC↗ |
| EBS Emergent BioSolutions Inc. | G Gift | 2012-12-14 | 2012-12-14 | 149,712 | — | $0 | 149,712 | SEC↗ |
| EBS Emergent BioSolutions Inc. | G Gift | 2012-12-14 | 2012-12-14 | 13,333 | — | $0 | 13,333 | SEC↗ |
| EBS Emergent BioSolutions Inc. | G Gift | 2012-12-12 | 2012-12-14 | 304,098 | — | $0 | 304,098 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2012-12-04 | 2012-12-06 | 43,064 | $15.08 | $649.4K | 1,845,570 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2012-12-03 | 2012-12-03 | 22,875 | $15.02 | $343.6K | 1,888,634 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2012-11-30 | 2012-12-03 | 34,061 | $15.21 | $518.1K | 1,911,509 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-09-18 | 2012-09-20 | 150,000 | — | $0 | 1,945,570 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-09-18 | 2012-09-20 | 150,000 | — | $0 | 4,344,250 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-06-04 | 2012-06-06 | 33,702 | — | $0 | 4,494,250 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-05-16 | 2012-05-17 | 191,950 | — | $0 | 4,527,952 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-05-16 | 2012-05-17 | 281,190 | — | $0 | 1,795,570 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-05-08 | 2012-05-09 | 45,647 | — | $0 | 5,591,147 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-05-08 | 2012-05-09 | 779,951 | — | $0 | 4,719,902 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-05-08 | 2012-05-09 | 45,647 | — | $0 | 5,499,853 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2012-05-08 | 2012-05-09 | 45,647 | — | $0 | 5,545,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2012-03-14 | 2012-03-16 | 3,538 | $16.05 | $56.8K | 1,514,380 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2012-03-13 | 2012-03-16 | 32,100 | — | $0 | 32,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2012-03-13 | 2012-03-16 | 16,050 | — | $0 | 1,517,918 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2012-03-08 | 2012-03-12 | 3,730 | $14.49 | $54.0K | 1,501,868 | SEC↗ |